Valuation: Cipla Limited

Market Cap 1,177B 12.38B 10.87B 10B 9.32B 17.58B 17.94B 120B 46.61B 578B 46.47B 45.47B 2,010B P/E 2027 *
28x
P/E 2028 * 22.9x
Enterprise Value 1,078B 11.34B 9.96B 9.16B 8.54B 16.1B 16.43B 110B 42.7B 529B 42.57B 41.65B 1,842B EV / Sales 2027 *
3.47x
EV / Sales 2028 * 3.03x
Free-Float
68.88%
Yield 2027 *
0.86%
Yield 2028 * 0.97%
1 day-0.05%
1 week+1.10%
Current month-0.64%
1 month+5.56%
3 months+22.11%
6 months-3.68%
Current year-3.66%
1 week 1,441.5
Extreme 1441.5
1,490.1
1 month 1,341.1
Extreme 1341.1
1,490.1
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 996.5
Extreme 996.5
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
President - 2026-05-17
Director of Finance/CFO - 2022-08-15
Director TitleAgeSince
Chairman 90 1972-07-20
Director/Board Member 72 2014-07-24
Director/Board Member 71 2021-06-29
Date Insider Type Main position Quantity % Market Cap.
24-08-21Sell 2,000 0.0002%
24-08-13Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.05%+1.10%-2.78%+45.34% 12.38B
+0.26%+0.44%+11.54%+81.18% 47.1B
+8.72%+6.96%+67.87%+119.19% 34.57B
-0.85%-0.15%+10.49%+90.15% 11.64B
+0.58%-1.91%+33.16%+121.55% 8.87B
+0.99%+0.82%+23.64%+46.15% 7.1B
+1.44%+2.63%+53.88%-7.74% 6.85B
+1.58%+1.93%+24.07%+233.00% 6.42B
+7.24%+8.88%-31.95%+9.65% 5.61B
-0.07%+5.18%+31.24%+126.80% 4.4B
Average +1.98%+1.08%+22.12%+86.53% 14.49B
Weighted average by Cap. +2.59%-0.04%+27.06%+89.79%

Financials

2027 *2028 *
Net sales 311B 3.27B 2.87B 2.64B 2.46B 4.64B 4.74B 31.77B 12.31B 153B 12.27B 12B 531B 347B 3.65B 3.2B 2.95B 2.75B 5.18B 5.29B 35.45B 13.74B 170B 13.69B 13.4B 592B
Net income 41.98B 442M 388M 357M 332M 627M 640M 4.29B 1.66B 20.6B 1.66B 1.62B 71.71B 51.42B 541M 475M 437M 407M 768M 784M 5.26B 2.04B 25.24B 2.03B 1.99B 87.84B
Net Debt -98.76B -1.04B -912M -839M -782M -1.48B -1.51B -10.1B -3.91B -48.48B -3.9B -3.82B -169B -125B -1.31B -1.15B -1.06B -990M -1.87B -1.9B -12.78B -4.95B -61.34B -4.93B -4.83B -213B
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
26-07-02 1,456.00 -0.05% 731,416
26-07-01 ₹1,456.70 -0.59% 753,439
26-06-30 ₹1,465.40 +0.78% 2,818,077
26-06-29 ₹1,454.10 +0.97% 4,162,869
26-06-25 ₹1,440.10 +0.15% 1,217,683
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,456.70INR
Average target price
1,463.62INR
Spread / Average Target
+0.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock